GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
13.867 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.9867 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, ADRB1, AKR1B1, AXL, CA2, CA7, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F10, F3, FLT3, HCAR2, HTR2A, HTR2B, HTR6, KDR, MET, MMP12, MMP9, PTPN1, SRC, XDH |
10.0647 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, ADRB1, AKR1B1, AXL, CA2, CA7, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F10, F3, FLT3, HCAR2, HTR2A, HTR2B, HTR6, KDR, MET, MMP12, MMP9, PTPN1, SRC, XDH |
10.0647 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, ADRB1, DRD1, EGFR, EPHX2, HTR1A, HTR2A, HTR2B, HTR7, SRC |
8.38159 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
8.29658 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALDH2, ALOX5, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, EPHX2, FABP3, FUT7, HTR2B, PIM1, PPARA, XDH |
8.19638 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, ADRB1, DRD1, EGFR, EPHX2, HTR1A, HTR2A, HTR2B, HTR7 |
8.08735 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, ADRB1, DRD1, EGFR, EPHX2, HTR1A, HTR2A, HTR2B, HTR7 |
8.08735 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, ADRB1, DRD1, EGFR, EPHX2, HTR1A, HTR2A, HTR2B, HTR7 |
7.85399 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, ADRB1, DRD1, EGFR, EPHX2, HTR1A, HTR2A, HTR2B, HTR7 |
7.83961 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, ADRB1, AKR1B1, AXL, CYP1B1, DRD2, EGFR, ERBB2, F10, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, PTPN1, SRC, XDH |
7.83447 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, ADRB1, DRD1, EGFR, EPHX2, HTR1A, HTR2A, HTR2B, HTR7, SRC |
7.36178 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, HTR2A, HTR2B, KDR, SRC |
7.30912 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, AKR1B1, CDC25B, CYP1B1, DRD2, DRD3, EGFR, ERBB2, F3, FABP3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, SRC, XDH |
7.15946 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.12255 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.12255 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, ADRB1, AKR1B1, AXL, CYP1B1, DRD2, DRD3, EGFR, ERBB2, F10, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, MMP12, MMP9, PTPN1, SRC, XDH |
7.08031 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
7.03406 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA1A, ADRB1, AKR1B1, AURKB, AXL, CA12, CA2, CA7, CACNA1C, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, EPHX2, F10, F3, FABP3, FABP4, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR7, KDR, MET, PPARA, SRC, XDH |
6.86232 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EGFR, HCAR2, HTR2A, HTR2B, KDR, SRC |
6.80271 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, ADRB1, AKR1B1, AURKB, AXL, CA2, CA7, CACNA1C, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F10, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, SRC, XDH |
6.78892 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, ADRB1, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR6, HTR7 |
6.72945 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, ADRB1, AKR1B1, AURKB, AXL, CA2, CA7, CACNA1C, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F10, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, SRC, XDH |
6.66732 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, ADRB1, AKR1B1, AKR1B10, ALOX5, ALPL, AXL, CACNA1C, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, EPHX2, F10, F3, FABP4, HTR1A, HTR2A, HTR2B, HTR7, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RORC, SRC |
6.56626 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, ADRB1, AKR1B1, AURKB, AXL, CYP1B1, DRD2, DRD3, EGFR, ERBB2, F10, F3, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
6.40966 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, ADRB1, AKR1B1, AXL, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EGFR, EPHX2, FABP3, FABP4, FLT3, HTR2A, HTR2B, MET, SRC |
6.40652 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, EGFR, ERBB2, F10, F3, MET, SRC, XDH |
6.19957 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, ADRB1, AKR1B1, AURKB, AXL, CA2, CA7, CDC25B, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F10, F3, FABP3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, XDH |
6.1421 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, ADRB1, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
6.11785 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CDC25B, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1 |
6.07387 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, AXL, CA2, CA7, CACNA1C, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F10, F3, HCAR2, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, SRC |
6.00536 |
[BP] GO:0006811 |
None
|
ADRA1A, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, PPARA |
5.9813 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
5.9813 |
[BP] GO:0042221 |
response to chemical
|
ADRA1A, AKR1B1, ALPL, AXL, CA2, CA3, CA9, CYP1B1, DRD1, DRD2, DRD3, EGFR, EPHX2, ERBB2, FABP3, FABP4, FLT3, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MMP2, MMP9, PPARA, RORC, SRC |
5.90046 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA1A, ADRB1, AKR1B1, AURKB, AXL, CA2, CA7, CDC25B, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, EPHX2, ERBB2, F10, F3, FABP3, FABP4, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, XDH |
5.84844 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, ADRB1, CACNA1C, DRD1, DRD2, DRD3, EGFR, HTR2B, HTR5A, KDR |
5.83151 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, EGFR, EPHX2, ERBB2, FABP3, FABP4, FUT7, MET, PPARA |
5.74957 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, ADRB1, AKR1B1, AXL, CYP1B1, DRD2, DRD3, EGFR, ERBB2, F10, F3, FABP4, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, MMP12, MMP2, MMP9, PTPN1, SRC, XDH |
5.70056 |
[BP] GO:0042493 |
response to drug
|
ADRA1A, AKR1B1, AXL, CA3, CA9, CYP1B1, DRD1, DRD2, DRD3, EGFR, FABP3, HTR2A, HTR2B, KDR, SRC |
5.48031 |
[BP] GO:0006939 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
5.47753 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
5.32681 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
5.26656 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, CACNA1C, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
5.25368 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, DRD3, EPHX2, FABP3, FLT3, HCAR2, HTR2A, HTR2B, PPARA, RORC, SRC |
5.18465 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, AKR1B1, ALPL, AXL, CA2, CA3, CA9, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, FABP3, FABP4, FLT3, HTR5A, IGF1R, KDR, MMP2, PPARA, RORC, SRC |
5.06697 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
5.00889 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, ADRB1, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CYP19A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, EGFR, EPHX2, ERBB2, F10, F3, FABP3, FABP4, FLT3, FUT7, HTR1A, HTR2B, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, XDH |
4.9886 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, AKR1B1, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EGFR, EPHX2, FABP3, FABP4, HTR2A, HTR2B, MET |
4.95241 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HTR2A |
4.9244 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HTR2A |
4.9244 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
4.92373 |
[BP] GO:0001659 |
None
|
ADORA1, ADRB1, DRD1, DRD2, HTR2A |
4.88768 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, EGFR, EPHX2, ERBB2, FABP3, FABP4, FUT7, MET, PPARA |
4.85955 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ADRB1, CDC25B, DRD1, DRD2, EGFR, ERBB2, FABP3, FLT3, HTR2A, HTR2B, KDR, MMP9, PTPN1, SRC, XDH |
4.85955 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ADRB1, CDC25B, DRD1, DRD2, EGFR, ERBB2, FABP3, FLT3, HTR2A, HTR2B, KDR, MMP9, PTPN1, SRC, XDH |
4.85955 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, DRD2 |
4.83519 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
4.83084 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, CA3, CYP1B1, DRD1, DRD2, DRD3, EPHX2, KDR, SRC |
4.81119 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ADRB1, CDC25B, DRD1, DRD2, DRD3, EGFR, ERBB2, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
4.79635 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ADRB1, CDC25B, DRD1, DRD2, DRD3, EGFR, ERBB2, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
4.74127 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, DRD2, EGFR, ERBB2, FLT3, HTR2A, HTR2B, KDR, PTPN1, SRC, XDH |
4.72738 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AXL, CA3, CA9, CYP1B1, DRD1, DRD2, DRD3, EGFR, FABP3, HTR5A, IGF1R, MMP2, MMP9, PPARA, RORC, SRC |
4.71721 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, AKR1B1, ALPL, AURKB, AXL, CA2, CA3, CA6, CA9, CYP1B1, DRD1, DRD2, DRD3, EGFR, EPHX2, ERBB2, F10, F3, FABP3, FABP4, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, SRC |
4.68134 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, EGFR, HTR6 |
4.67466 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, ADRB1, AKR1B1, DRD1, DRD2, HTR2A, MET |
4.61378 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, ALDH2, CYP1B1, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, EGFR, EPHX2 |
4.60019 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, EGFR |
4.55445 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.55445 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CYP1B1, EGFR, F3, FLT3, HCAR2, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SIGMAR1, SRC, XDH |
4.55428 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
4.51444 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.49242 |
[BP] GO:0007193 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
4.4544 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.44719 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EGFR, EPHX2, FABP3, HTR2A, HTR2B |
4.40177 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CYP1B1, EGFR, F3, FLT3, HCAR2, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SIGMAR1, SRC, XDH |
4.3842 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, AXL, CA2, CA7, CACNA1C, CYP19A1, DRD1, DRD2, DRD3, EGFR, ERBB2, HCAR2, HTR1A, HTR2A, HTR2B, MMP12, MMP9, PPARA, PTPN1, SRC |
4.3842 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA1A, ADRB1, AKR1B1, AXL, CACNA1C, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MET, PTPN1, SRC |
4.35882 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, ADRB1, AKR1B1, AXL, CA1, CA2, CACNA1C, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SIGMAR1, SRC |
4.35151 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, EGFR, ERBB2, FLT3, IGF1R, KDR, PIM1, SRC |
4.34968 |
[BP] GO:0045776 |
None
|
ADORA1, ADRB1, DRD2, DRD3, PPARA |
4.33697 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, DRD2, EGFR, ERBB2, HTR2A, HTR2B, KDR, PTPN1, SRC |
4.33697 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CACNA1C, CYP19A1, DRD2, DRD3, EGFR, HCAR2, HTR1A, HTR2A, HTR2B, MMP12, SRC |
4.33697 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
4.29511 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA1A, ADRB1, DRD1, EGFR, EPHX2, HTR1A, HTR2A, HTR2B, HTR7 |
4.26374 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, HTR2B, MMP12, SRC |
4.12941 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, DRD2, EGFR, ERBB2, FLT3, HTR2A, HTR2B, IGF1R, KDR, PTPN1, SRC, XDH |
4.0976 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, AKR1B1, ALPL, CA2, CA9, DRD1, EGFR, ERBB2, FABP3, FLT3, HTR5A, IGF1R, MMP2, PPARA, SRC |
4.08947 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
4.07549 |
[BP] GO:0019933 |
None
|
ADRA1A, ADRB1, DRD1, DRD2, DRD3, HTR5A |
4.05427 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, ADRB1, CA2, DRD1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1, SRC |
4.05054 |
[BP] GO:0008217 |
None
|
ADORA1, ADRA1A, ADRB1, DRD2, DRD3, EPHX2, PPARA |
4.03042 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
4.02048 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CACNA1C, CYP19A1, DRD2, DRD3, EGFR, HCAR2, HTR1A, HTR2A, HTR2B, MMP12, SRC |
4.01726 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1B1, CYP2A13, CYP2A6, EPHX2 |
4.0053 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, F10, F3, MET, SRC |
3.98535 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CACNA1C, CYP19A1, CYP1B1, DRD2, EGFR, HCAR2, HTR1A, HTR2A |
3.94899 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HCAR2 |
3.94649 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1B1, CYP2A13, CYP2A6, CYP2D6, EPHX2 |
3.92007 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1B1, CYP2A13, CYP2A6, CYP2D6, EPHX2 |
3.85468 |
[BP] GO:0019935 |
None
|
ADRA1A, ADRB1, DRD1, DRD2, DRD3, HTR5A |
3.85468 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, CDC25B, DRD1, DRD2, EGFR, ERBB2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
3.84591 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CYP1B1, EGFR, F3, FLT3, HCAR2, HTR2B, IGF1R, KDR, MMP9, PIM1, PTPN1, SIGMAR1, SRC, XDH |
3.84483 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EGFR, EPHX2, HTR2A, HTR2B |
3.83685 |
[BP] GO:0007202 |
None
|
ADRA1A, EGFR, HTR2A, HTR2B |
3.79752 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1B1, CYP2A13, CYP2A6, CYP2D6, EPHX2 |
3.76973 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP2A13, CYP2A6, CYP2D6 |
3.767 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP2A13, CYP2A6, CYP2D6 |
3.767 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, ADRB1, AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, F3, HCAR2, HTR2A, HTR2B, KDR, MET, MMP12, MMP9, PIM1, SRC |
3.74608 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, CDC25B, DRD1, DRD2, EGFR, ERBB2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PTPN1, SRC, XDH |
3.70897 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, EGFR, HTR2A |
3.69773 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.69414 |
[BP] GO:0051234 |
None
|
ACHE, ADORA1, ADRA1A, ALOX5, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, DRD1, DRD2, DRD3, EGFR, F10, FABP3, HTR2A, HTR2B, MMP12, MMP9, PPARA, SIGMAR1, SRC, XDH |
3.67099 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, HTR2A, HTR2B, IGF1R, PTPN1, SRC |
3.67099 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CYP19A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, EGFR, EPHX2, ERBB2, F10, FABP3, FABP4, FLT3, FUT7, HTR1A, HTR2B, IGF1R, KDR, MET, MMP1, MMP2, PIM1, PPARA, PTPN1, RORC, SRC, XDH |
3.67099 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA1A, CDC25B, DRD2, EGFR, ERBB2, FLT3, HTR2A, HTR2B, KDR, MMP9, PTPN1, SRC, XDH |
3.6193 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, EGFR, HCAR2, HTR2B, MMP12, SRC |
3.6193 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, CA2, CACNA1C, DRD2, DRD3, EGFR, ERBB2, HCAR2, HTR2B, MMP12, PTPN1, SRC |
3.60371 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, EGFR, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
3.60094 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.60094 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.60094 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, CACNA1C, DRD2, DRD3, EGFR, HCAR2, HTR2B, MMP12, SRC |
3.59228 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, HTR2A |
3.5568 |
[BP] GO:0060402 |
None
|
ADRA1A, CACNA1C, DRD2, HTR2A, HTR2B |
3.5568 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, DRD1, DRD2, DRD3, HTR1A |
3.55564 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, AXL, CA2, CYP19A1, DRD1, DRD2, DRD3, EGFR, ERBB2, HCAR2, HTR2B, MMP12, SRC |
3.55464 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, CACNA1C, CYP19A1, DRD2, EGFR, HCAR2, HTR1A, HTR2A |
3.54648 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, HTR2A, HTR2B, PTPN1, SRC |
3.53685 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, CA2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, SRC |
3.52586 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, AURKB, AXL, CA3, CDC25B, DRD1, DRD2, EGFR, EPHX2, ERBB2, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, PTPN1, SRC, XDH |
3.52509 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, SRC |
3.50473 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA1A, DRD1, DRD2, DRD3, EGFR, ERBB2, HTR2A, IGF1R, MET, MMP12, MMP9, PTPN1, SRC, XDH |
3.48757 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA1A, DRD1, DRD2, DRD3, EGFR, ERBB2, HTR2A, IGF1R, MET, MMP12, MMP9, PTPN1, SRC, XDH |
3.47262 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, ADRB1, AKR1B1, ALPL, AURKB, AXL, CA2, CA9, CACNA1C, CDC25B, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, FABP4, FLT3, FUT7, HTR2A, HTR2B, HTR5A, KDR, MET, MMP2, MMP9, PIM1, PPARA, RORC, SIGMAR1, SRC |
3.46997 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA1A, ADRB1, AKR1B1, AURKB, AXL, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F10, F3, FABP4, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PPARA, PTPN1, SRC, XDH |
3.46997 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CDC25B, CYP19A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, EGFR, EPHX2, ERBB2, F10, F3, FABP3, FABP4, FLT3, FUT7, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SIGMAR1, SRC, XDH |
3.46997 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B |
3.46997 |
[BP] GO:0006810 |
None
|
ACHE, ADORA1, ADRA1A, ALOX5, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, DRD1, DRD2, DRD3, F10, FABP3, HTR2A, HTR2B, MMP12, MMP9, PPARA, SIGMAR1, SRC, XDH |
3.45879 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA1A, CDC25B, DRD2, EGFR, ERBB2, FLT3, HTR2A, HTR2B, KDR, MMP9, PTPN1, SRC, XDH |
3.45539 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, PPARA, SRC |
3.4409 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
ERBB2, HTR2A, HTR2B, IGF1R |
3.43648 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, ADRB1, AKR1B1, AURKB, CA2, DRD1, DRD2, DRD3, EGFR, HTR2A, HTR2B, MMP2, PPARA, SRC |
3.39598 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, CA2, CA9, CYP1B1, DRD1, DRD2, DRD3, EGFR, FLT3, HTR5A, RORC, SRC |
3.39598 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, EGFR, HTR6 |
3.38909 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, DRD2, EGFR, HTR2A, HTR2B, KDR, SRC |
3.38252 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, ALDH2, AURKB, CYP19A1, CYP1B1, CYP2A6, CYP2D6, EPHX2, FABP3, FABP4, FUT7, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
3.37745 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
3.36648 |
[BP] GO:0007189 |
None
|
ADRA1A, ADRB1, DRD1, DRD2, DRD3 |
3.36648 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, EGFR, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC |
3.3658 |
[BP] GO:0048511 |
rhythmic process
|
AXL, DRD2, DRD3, EGFR, HTR7, PPARA, RORC, SRC |
3.36285 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA1A, ADRB1, CACNA1C, DRD2, EGFR, HTR2A |
3.35478 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, EGFR, HTR2A, HTR2B |
3.35478 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA1A, ADRB1, AURKB, CDC25B, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FABP3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, XDH |
3.32668 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MET, MMP1, MMP12, MMP9, SRC |
3.3202 |
[BP] GO:0051179 |
None
|
ACHE, ADORA1, ADRA1A, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, DRD1, DRD2, DRD3, EGFR, F10, FABP3, HTR2A, HTR2B, MMP12, MMP9, PPARA, SIGMAR1, SRC, XDH |
3.30957 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, AURKB, AXL, CA3, CDC25B, DRD1, DRD2, EGFR, EPHX2, ERBB2, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, PTPN1, SRC, XDH |
3.28974 |
[BP] GO:0051952 |
None
|
ADORA1, DRD1, DRD2, DRD3, HTR2A |
3.27698 |
[BP] GO:0060401 |
None
|
ADRA1A, CACNA1C, DRD2, HTR2A, HTR2B |
3.27698 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA1A, ADRB1, AURKB, CDC25B, DRD1, DRD2, DRD3, EGFR, EPHX2, ERBB2, F3, FABP3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, XDH |
3.26787 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1B1, CYP2A13, CYP2A6, CYP2D6, EPHX2, FABP3, PPARA |
3.25487 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EGFR, EPHX2, HTR2A, HTR2B |
3.24649 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, EGFR, HTR7, PPARA, RORC |
3.24504 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
3.24504 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, ADRB1, AKR1B1, AURKB, AXL, CYP1B1, DRD2, DRD3, EGFR, ERBB2, F10, F3, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, SRC, XDH |
3.24374 |
[BP] GO:0018958 |
None
|
AKR1B1, DRD1, DRD2, DRD3, HTR1A |
3.23617 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ADRA1A, EGFR, HTR2A, HTR2B |
3.23225 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, DRD2, EGFR, ERBB2, FLT3, HTR2A, HTR2B, PTPN1, SRC |
3.21491 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
3.18984 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA1A, ADRB1, CACNA1C, DRD2, DRD3, EGFR, HCAR2, HTR2A |
3.1821 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, SRC |
3.15814 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, ADRB1, AURKB, CDC25B, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MMP9, PTPN1, SRC, XDH |
3.15814 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA1A, ADRB1, AURKB, CDC25B, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, XDH |
3.13193 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, EGFR, F3, FABP4, KDR, MET, MMP12, PPARA |
3.12998 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALDH2, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, HTR1A |
3.1289 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA1A, ADRB1, AURKB, CDC25B, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, XDH |
3.11487 |
[BP] GO:0051781 |
None
|
AURKB, CDC25B, DRD2, DRD3, HTR2B |
3.10643 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, CDC25B, DRD2, EGFR, ERBB2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, PTPN1, SRC |
3.10643 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, CACNA1C, DRD1, DRD2, DRD3, EGFR, EPHX2, HTR2A, HTR2B |
3.10521 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, AKR1B1, ALPL, CA2, CA9, EGFR, FABP3, FLT3, HTR5A, PPARA, SRC |
3.09149 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, CDC25B, DRD1, EGFR, ERBB2, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, SRC |
3.0872 |
[BP] GO:0050708 |
None
|
ACHE, CACNA1C, DRD2, DRD3, EGFR, HCAR2, HTR2B, MMP12, SRC |
3.06331 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
3.05815 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
3.05815 |
[BP] GO:0007200 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B |
3.05048 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, DRD2, EGFR, ERBB2, FLT3, HTR2A, HTR2B, PTPN1, SRC |
3.01683 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
3.01683 |
[BP] GO:0001997 |
None
|
ADRA1A, ADRB1 |
3.01319 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, DRD3, HTR2A, MET |
3.01143 |
[BP] GO:0050714 |
None
|
ACHE, DRD2, EGFR, HCAR2, HTR2B, MMP12, SRC |
2.9882 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1B1, CYP2A13, CYP2A6, CYP2D6, EPHX2 |
2.98599 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.98062 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.98062 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.97652 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.97652 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, DRD2, EGFR, ERBB2, FLT3, HTR2A, HTR2B, PTPN1, SRC |
2.96932 |
[BP] GO:0030335 |
positive regulation of cell migration
|
DRD1, EGFR, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
2.95051 |
[BP] GO:0071702 |
None
|
ADORA1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, FABP3, MMP12, PPARA, SIGMAR1 |
2.93291 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EPHX2, HTR2A, HTR2B |
2.91691 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.89648 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA1A, AURKB, CDC25B, DRD1, DRD2, DRD3, EGFR, EPHX2, ERBB2, F3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, XDH |
2.8558 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, CYP19A1, DRD1, DRD2, DRD3, EGFR, ERBB2, IGF1R, MET, MMP12, MMP9, PPARA, PTPN1, SRC, XDH |
2.85234 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, KDR, SRC |
2.85123 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, CDC25B, DRD2, EGFR, ERBB2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, PTPN1, SRC |
2.85047 |
[BP] GO:2000147 |
positive regulation of cell motility
|
DRD1, EGFR, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
2.85047 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, PPARA, RORC |
2.8461 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EPHX2, HTR2A, HTR2B |
2.84307 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, HTR2A, HTR2B, PTPN1, SRC |
2.83088 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, EGFR, HTR2B, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC |
2.83088 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA1A, ADRB1, AXL, CA2, CACNA1C, CYP1B1, DRD2, DRD3, EGFR, ERBB2, F3, HCAR2, HTR2A, HTR2B, KDR, MET, MMP12, MMP9, PIM1, SRC, XDH |
2.83088 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B |
2.83088 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3 |
2.83088 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1B1, CYP2A13, CYP2A6, CYP2D6, EPHX2 |
2.81675 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CYP1B1, CYP2D6, DRD2, DRD3, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
2.81254 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, EGFR, HTR1A |
2.81227 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ADRA1A, EGFR, HTR2A, HTR2B |
2.80707 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HTR2A, MET, SRC |
2.80707 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HTR2A, MET, SRC |
2.80707 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HTR2A, MET, SRC |
2.80707 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HTR2A, MET, SRC |
2.80707 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, DRD2, EGFR, HCAR2, HTR2B, MMP12, SRC |
2.80528 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, AURKB, CDC25B, DRD2, EGFR, ERBB2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, PTPN1, SRC |
2.7989 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
DRD1, EGFR, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
2.78544 |
[BP] GO:0097755 |
None
|
ADRB1, DRD1, EGFR, EPHX2 |
2.77937 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
2.76833 |
[BP] GO:0050679 |
None
|
EGFR, ERBB2, F3, HTR2B, KDR, MMP12 |
2.75583 |
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
2.73454 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
ADRB1, MMP1, MMP12, MMP2, MMP9 |
2.71802 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, DRD2, EGFR, ERBB2, PPARA |
2.70639 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, HTR1A, HTR2A, MMP9 |
2.70639 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.69948 |
[BP] GO:0040017 |
positive regulation of locomotion
|
DRD1, EGFR, F10, F3, IGF1R, KDR, MET, MMP9, SRC |
2.67838 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA1A, CDC25B, DRD2, EGFR, ERBB2, FLT3, HTR2A, HTR2B, KDR, MMP9, PTPN1, SRC, XDH |
2.67192 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, AXL, CYP1B1, DRD1, EGFR, ERBB2, FABP4, FLT3, IGF1R, KDR, MMP2, RORC, SRC |
2.64182 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA1A, ADRB1, AURKB, CDC25B, DRD2, EGFR, ERBB2, F3, FLT3, HTR2A, HTR2B, MET, MMP9, PTPN1, SRC, XDH |
2.64171 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA1A, ADRB1, AKR1B1, CYP1B1, DRD1, DRD2, DRD3, EGFR, EPHX2, HTR1A, HTR2A, HTR2B, HTR7, SRC |
2.64171 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.63721 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.63721 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC |
2.63721 |
[BP] GO:0001996 |
None
|
ADRA1A, ADRB1 |
2.63721 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.63721 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.63721 |
[BP] GO:0003099 |
None
|
ADRA1A, ADRB1 |
2.63721 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DRD1, DRD2, DRD3, EGFR, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC |
2.63543 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, CACNA1C, DRD1, DRD2, DRD3, EPHX2, HTR2A, HTR2B |
2.63277 |
[BP] GO:0051282 |
None
|
CACNA1C, DRD1, DRD2, HTR2A, HTR2B |
2.61256 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, HTR2A, HTR2B, IGF1R, PTPN1, SRC |
2.59942 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, AKR1B1, AURKB, AXL, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, FABP3, FABP4, HCAR2, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, XDH |
2.59942 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1B1, CYP2A13, CYP2D6, EPHX2, RORC |
2.59849 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, EGFR, KDR, SRC |
2.5901 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.5901 |
[BP] GO:0071880 |
None
|
ADRA1A, ADRB1, DRD2 |
2.5901 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AURKB, AXL, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, FABP3, FABP4, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, XDH |
2.58992 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA1A, CDC25B, DRD1, DRD2, EGFR, ERBB2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PTPN1, SRC, XDH |
2.58911 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, CACNA1C, DRD1, DRD2, DRD3, EPHX2, HTR2A, HTR2B |
2.55441 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
2.55295 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA1A, ADRB1, AURKB, CDC25B, DRD2, EGFR, ERBB2, F3, FLT3, HTR2A, HTR2B, PTPN1, SRC, XDH |
2.55094 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
ADRA1A, EGFR, HTR2A, HTR2B |
2.54752 |
[BP] GO:0051223 |
None
|
ACHE, CACNA1C, DRD2, DRD3, EGFR, ERBB2, HCAR2, HTR2B, MMP12, PTPN1, SRC |
2.54706 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.53672 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ADRA1A, DRD2, DRD3, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
2.52917 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, CACNA1C, DRD1, DRD2, DRD3, EPHX2, HTR2A, HTR2B |
2.52528 |
[BP] GO:0048015 |
phosphatidylinositol-mediated signaling
|
ERBB2, HTR2A, HTR2B, IGF1R |
2.49882 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ADRA1A, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EPHX2, HTR2A, HTR2B |
2.49882 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
ADRB1, AURKB, DRD1, DRD2, DRD3, EGFR, ERBB2, FABP3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, PPARA, RORC, SRC |
2.48983 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
ADRA1A, EGFR, HTR2A, HTR2B |
2.47458 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.42523 |
[BP] GO:0048017 |
inositol lipid-mediated signaling
|
ERBB2, HTR2A, HTR2B, IGF1R |
2.42287 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.39768 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.38035 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DRD1, DRD2, DRD3, EGFR, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC |
2.3749 |
[BP] GO:0071875 |
None
|
ADRA1A, ADRB1, DRD2 |
2.3749 |
[BP] GO:0055065 |
metal ion homeostasis
|
ADRA1A, CACNA1C, DRD1, DRD2, DRD3, EGFR, EPHX2, HTR2A, HTR2B |
2.36984 |
[BP] GO:0070201 |
None
|
ACHE, CACNA1C, DRD2, DRD3, EGFR, ERBB2, HCAR2, HTR2B, MMP12, PTPN1, SRC |
2.36379 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, AXL, CYP1B1, DRD1, EGFR, ERBB2, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, RORC, SRC |
2.35746 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, FABP3, PPARA |
2.35513 |
[BP] GO:0006936 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
2.34563 |
[BP] GO:0032465 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.33246 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, CDC25B, DRD1, EGFR, ERBB2, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, SRC |
2.31379 |
[BP] GO:1903524 |
None
|
ADRA1A, ADRB1, EGFR, HTR2A |
2.28568 |
[BP] GO:0023052 |
None
|
ADORA1, ADRA1A, ADRB1, CACNA1C, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
2.28244 |
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3 |
2.28244 |
[BP] GO:0030534 |
None
|
DRD1, DRD2, DRD3, HTR2A, PPARA |
2.22463 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.22182 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, CDC25B, DRD2, EGFR, ERBB2, F3, FLT3, HTR2A, HTR2B, KDR, MMP9, PTPN1, SRC, XDH |
2.22182 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, DRD2, DRD3, HTR2A, MMP9 |
2.21384 |
[BP] GO:0050678 |
None
|
EGFR, ERBB2, F3, HTR2B, KDR, MMP12, XDH |
2.2127 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3 |
2.1951 |
[BP] GO:0014059 |
None
|
DRD2, DRD3, HTR2A |
2.1951 |
[BP] GO:0051302 |
None
|
AURKB, CDC25B, DRD2, DRD3, HTR2B |
2.1951 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.1951 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.1951 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.1951 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.1951 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.1951 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.1951 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B |
2.1951 |
[BP] GO:0050730 |
None
|
ADORA1, EGFR, FLT3, HTR2A, PTPN1, SRC |
2.19113 |
[BP] GO:0007154 |
None
|
ADORA1, ADRA1A, ADRB1, AXL, CACNA1C, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
2.19113 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, CA2, CA9, EGFR, FABP3, FLT3, HTR5A, RORC, SRC |
2.18925 |
[BP] GO:0032845 |
None
|
ADORA1, DRD2, HTR2A, HTR2B, SRC |
2.18925 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9 |
2.1748 |
[BP] GO:1900542 |
None
|
ADRB1, DRD1, DRD2, DRD3, HTR2A, PPARA |
2.16588 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, DRD1, EGFR, ERBB2, F10, FLT3, IGF1R, KDR, MET, SRC |
2.15767 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
AXL, CYP1B1, DRD1, DRD2, EGFR, ERBB2, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, SRC |
2.14123 |
[BP] GO:0008016 |
None
|
ADORA1, ADORA3, ADRA1A, ADRB1, CACNA1C, DRD2 |
2.1404 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AXL, CA3, CYP1B1, EGFR, MMP9, SRC |
2.13419 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, AXL, CA2, CACNA1C, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, FLT3, HTR5A, KDR, MMP9, PIM1, PPARA, RORC, SIGMAR1, SRC |
2.12348 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.11892 |
[BP] GO:0006140 |
None
|
ADRB1, DRD1, DRD2, DRD3, HTR2A, PPARA |
2.10545 |
[BP] GO:0045744 |
None
|
DRD2, DRD3, MET |
2.08763 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.08146 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, CYP1B1, DRD1, EGFR, FLT3, RORC, SRC |
2.08054 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
ADRB1, AURKB, DRD1, DRD2, DRD3, EGFR, ERBB2, FABP3, HTR2A, HTR2B, IGF1R, MET, MMP12, PPARA, RORC, SRC |
2.07841 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1B1, CYP2A6, CYP2D6 |
2.0574 |
[BP] GO:0098801 |
None
|
ADORA1, DRD2, DRD3 |
2.0574 |
[BP] GO:0042596 |
None
|
ADRB1, DRD1, HTR1A |
2.0574 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CYP1B1, DRD1, EGFR, IGF1R, MMP2, MMP9, RORC, SRC |
2.0574 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
ADRA1A, CACNA1C, DRD1, DRD2, HTR2A, HTR2B |
2.0574 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.0574 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.0574 |
[BP] GO:0003057 |
None
|
ADRA1A, ADRB1 |
2.0574 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.0574 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1B1, CYP2A13, CYP2A6, CYP2D6, EPHX2, FABP3, PPARA |
2.05245 |
[BP] GO:0051222 |
positive regulation of protein transport
|
ACHE, DRD2, EGFR, ERBB2, HCAR2, HTR2B, MMP12, SRC |
2.04119 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HTR2A, MET, SRC |
2.03619 |
[BP] GO:0045907 |
None
|
ADRA1A, EGFR, HTR2A |
2.02942 |
[BP] GO:0060191 |
regulation of lipase activity
|
ADRA1A, EGFR, HTR2A, HTR2B |
2.02425 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
ADRA1A, CACNA1C, DRD1, DRD2, DRD3, EPHX2, HTR2A, HTR2B |
2.02218 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA1A, CDC25B, DRD2, EGFR, ERBB2, F3, FLT3, HTR2A, HTR2B, KDR, MMP9, PTPN1, SRC, XDH |
2.01294 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.00792 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, ADRB1, AXL, CA4, DRD1, DRD2, DRD3, F10, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
6.59315 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA1A, ADRB1, AXL, CA2, CA4, CA9, CACNA1C, DRD1, DRD2, DRD3, EGFR, ERBB2, F10, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, SRC |
5.90046 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, DRD1, DRD2, DRD3, EGFR, ERBB2, F10, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, SRC |
5.26656 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, ADRB1, AXL, DRD1, DRD2, DRD3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
4.83084 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CYP19A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, F10, F3, FLT3, FUT7, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PTPN1, SIGMAR1, SRC |
3.39598 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, ALOX5, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CYP19A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, F10, F3, FLT3, FUT7, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, SIGMAR1, SRC |
3.10643 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA1A, CA2, CA4, CA9, DRD1, DRD2, EGFR, ERBB2, HTR2A, MET, SIGMAR1, SRC |
2.92255 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, ERBB2 |
2.63543 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.5901 |
[CC] GO:0031224 |
None
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, ALPL, AXL, CA12, CA14, CA4, CA9, CACNA1C, DRD1, DRD2, DRD3, EGFR, ERBB2, F10, F3, FLT3, FUT7, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
2.28389 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.0574 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
20.2845 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.9867 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.493 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, XDH |
11.4599 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, EGFR, EPHX2, ERBB2, F10, F3, FABP3, FABP4, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, XDH |
11.4599 |
[MF] GO:0008227 |
None
|
ADRA1A, ADRB1, DRD2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
9.39906 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRB1, AXL, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC, SIGMAR1 |
9.22834 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, EPHX2, F10, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, XDH |
8.64695 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
8.49747 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRB1, AXL, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
8.37818 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRB1, AXL, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
8.37818 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRB1, AXL, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC, SIGMAR1 |
8.26846 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, ADRB1, AXL, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC, SIGMAR1 |
8.05374 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
7.83447 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, ADRB1, AXL, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC, SIGMAR1 |
7.51572 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.25751 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.12255 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.12255 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
7.08031 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
7.08031 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CYP19A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, EGFR, EPHX2, ERBB2, F10, F3, FLT3, FUT7, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, SRC, XDH |
6.84908 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC |
6.57992 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
6.29411 |
[MF] GO:0099528 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.03009 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.65442 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CYP19A1, CYP1B1, CYP2A13, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, PIM1, PPARA, SIGMAR1, SRC |
5.46034 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
5.28083 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
5.24515 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, ADRB1, DRD1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
4.67466 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.56245 |
[MF] GO:1901338 |
None
|
ADRB1, DRD1, DRD2, DRD3 |
4.07549 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1B1, CYP2A13, CYP2D6 |
3.85468 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, XDH |
3.85468 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, EPHX2, F10, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, XDH |
3.767 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, ERBB2, KDR |
3.46997 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, SRC |
3.3658 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP2A13, CYP2A6, CYP2D6 |
3.30957 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, SRC |
3.21891 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
3.14179 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, FLT3, HTR2A, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SRC |
3.09014 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
3.05815 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
3.01319 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, ALDH2, XDH |
2.94925 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1B1, CYP2A13, CYP2D6 |
2.91691 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
2.89812 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, EGFR, FLT3, HTR2A, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SRC |
2.8891 |
[MF] GO:0004935 |
None
|
ADRA1A, ADRB1, DRD2 |
2.83088 |
[MF] GO:0017171 |
serine hydrolase activity
|
ACHE, F10, F3, MMP1, MMP12, MMP2, MMP9 |
2.58609 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.49882 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALDH2, ALOX5, CYP19A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, XDH |
2.15542 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.08763 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
2.05808 |
[MF] GO:0004252 |
None
|
F10, F3, MMP1, MMP12, MMP2, MMP9 |
2.0574 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.0574 |
[MF] GO:0048037 |
cofactor binding
|
ALDH2, CYP19A1, CYP1B1, CYP2A13, CYP2A6, CYP2D6, SRC, XDH |
2.03111 |